Great news for Nieman-Pick Disease #patients Good thing @EngageHealthInc and @nnpdf did their burden of access study to understand the health insurance literacy of their patients and barriers to accessing coverage through insurance back in 2020! :)
https://t.co/0brXYDav4x
Today, the @US_FDA approved the first and only therapy for non-CNS manifestations of #ASMD, a progressive and #RareDisease. Read more: https://t.co/Nph12cYnfH
Today, the @US_FDA approved the first and only therapy for non-CNS manifestations of #ASMD, a progressive and #RareDisease. Read more: https://t.co/Nph12cYnfH
The registration link for the Patient Advocate Certificate Training (PACT) course, a collaboration between @SanfordResearch, @SanfordCoRDS, and Professional Patient Advocates in Life Sciences (PPALS) is now available online at https://t.co/5b0K53z3BI
The end of the first day of @RareAdvocates@EveryLifeOrg#RareDisease week has got me feeling humbled. So many excellent people doing excellent things! It's been a pleasure meeting new people and catching up with old friends. See you all tomorrow! #RareDC2019#SanfordRARE
Stop by the @SanfordCoRDS booth at @RareAdvocates Legislative Conference! Learn how we can help build your patient registry - more important, grab a pair of CoRDS sunglasses and a fist full of candy :) #RareDC2019#SanfordRARE
It's the first of the month again ... which means a new episode of CoRDS Cast is out! Listen to us speak with Sharon Nissley and Emily Lemiska from Klippel-Feil Syndrome Freedom and Dr. Philip Giampietro to learn more about klippel…https://t.co/Xgnq2vEzNP https://t.co/X6fPLX0TiP
This July 13th, Global Genes and EveryLife Foundation for Rare Diseases will be hosting a Rare on the Road at Sanford Research in Sioux Falls, SD! #raredisease Don't forget to register today: https://t.co/RMjG0Dx0aC
If you were unable to join @SanfordCoRDS yesterday for our webinar, please follow the link below and check it out! HUGE thanks to @Srotberg15 and Rob Pyatt for contributing and sharing their excellent perspectives! https://t.co/wHPeFPPlnD